OTCMKTS:RGIN Regenicin (RGIN) Stock Price, News & Analysis → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free RGIN Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume225,156 shsMarket Capitalization$17,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Regenicin alerts: Email Address Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> About Regenicin Stock (OTCMKTS:RGIN)Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.Read More Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> RGIN Stock News HeadlinesJune 17 at 11:40 AM | americanbankingnews.comAnalyzing Regenicin (OTCMKTS:RGIN) & Surmodics (NASDAQ:SRDX)May 3, 2024 | bbc.co.ukLGBT+ History Month - Teaching ResourcesJanuary 20, 2024 | foxnews.comJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'December 9, 2023 | thestreet.comHistory of Walmart: Timeline and FactsAugust 22, 2023 | foxnews.comHeavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 deadJune 13, 2023 | bbc.comUkraine army attacks Russian forces in southern Zaporizhzhia regionJune 5, 2023 | fortune.comRegions FinancialApril 21, 2023 | reuters.comRussia's Promsvyazbank opening more branches in annexed regions of UkraineApril 11, 2023 | bbc.co.ukTundra regions of the worldMarch 28, 2023 | health.usnews.comRegions HospitalMarch 18, 2023 | news.yahoo.comDrought risk to England regions after dry February, scientists warnMarch 17, 2023 | fool.comRegions Bank Review: A Great Place for All-in-One BankingMarch 16, 2023 | usatoday.comNCAA Tournament South Region breakdown: Alabama clearly the favorite but championship pedigree lurksMarch 4, 2023 | bbc.co.ukWelsh rugby crisis: Regions braced to lose star names amid budget cutsMarch 4, 2023 | cbsnews.comCalifornia drought update: Winter storm lifts regions out of droughtFebruary 24, 2023 | skift.comSee What Regions of the World Are Fully Recovered: New Skift Travel Health IndexFebruary 18, 2023 | cbsnews.comDog flu cases on the rise in some U.S. regions this winter seasonFebruary 14, 2023 | usnews.comUkraine Says Three Major Regions Can Avoid Power Cuts After AttacksOctober 29, 2022 | reuters.comRGIN.PK - Regenicin Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.comRussia's Federation Council ratifies annexation of four Ukrainian regionsOctober 4, 2022 | reuters.comRussian parliament to consider legal steps to absorb Ukrainian regionsSeptember 25, 2022 | marketwatch.comUkraine regions largely under control of Moscow-aligned separatists vote in referendums on joining RussiaSeptember 24, 2022 | theguardian.comFour occupied Ukraine regions plan imminent ‘votes’ on joining RussiaAugust 30, 2022 | ca.finance.yahoo.comThe Global Tissue Engineered Skin Substitutes Market grew USD 1,784.48 million by 2027, at a CAGR of 12.23%.February 11, 2022 | nasdaq.comRGIN Pre-Market QuotesSee More Headlines Receive RGIN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regenicin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/19/2020Today6/17/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:RGIN CUSIPN/A CIK1412659 Webwww.regenicin.com Phone(732) 757-5500FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / BookN/AMiscellaneous Outstanding Shares165,770,000Free FloatN/AMarket Cap$17,000.00 OptionableNot Optionable Beta-18.89 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Randall E. McCoy (Age 75)Chairman, CEO & President Comp: $250kMr. John J. Weber (Age 74)CFO & Director Comp: $125kDr. J. Roy Nelson Ph.D. (Age 76)Controller & Chief Science Officer Comp: $150kKey CompetitorsCVR MedicalOTCMKTS:CRRVFViatar CTC SolutionsOTCMKTS:VRTTMedifocusOTCMKTS:MDFZFiNeedMDOTCMKTS:NEMDRenovaCareOTCMKTS:RCARView All Competitors RGIN Stock Analysis - Frequently Asked Questions How were Regenicin's earnings last quarter? Regenicin, Inc. (OTCMKTS:RGIN) issued its quarterly earnings data on Wednesday, August, 19th. The company reported $0.00 earnings per share (EPS) for the quarter. What other stocks do shareholders of Regenicin own? Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), (ZINCQ) (ZINCQ), Ambarella (AMBA) and Alstom (ALO). How do I buy shares of Regenicin? Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RGIN) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regenicin, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regenicin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.